DK0637306T3 - 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi - Google Patents
4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapiInfo
- Publication number
- DK0637306T3 DK0637306T3 DK93908559T DK93908559T DK0637306T3 DK 0637306 T3 DK0637306 T3 DK 0637306T3 DK 93908559 T DK93908559 T DK 93908559T DK 93908559 T DK93908559 T DK 93908559T DK 0637306 T3 DK0637306 T3 DK 0637306T3
- Authority
- DK
- Denmark
- Prior art keywords
- serotonin
- antagonists
- imidomethyl
- oxoethyl
- piperidines
- Prior art date
Links
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical class C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87256692A | 1992-04-23 | 1992-04-23 | |
US2250293A | 1993-03-10 | 1993-03-10 | |
PCT/US1993/002771 WO1993022309A1 (en) | 1992-04-23 | 1993-03-24 | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0637306T3 true DK0637306T3 (da) | 2001-07-30 |
Family
ID=26695998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93908559T DK0637306T3 (da) | 1992-04-23 | 1993-03-24 | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi |
Country Status (15)
Country | Link |
---|---|
US (3) | US20020002174A1 (de) |
EP (1) | EP0637306B1 (de) |
JP (1) | JP3333878B2 (de) |
KR (1) | KR100259107B1 (de) |
AT (1) | ATE201677T1 (de) |
AU (1) | AU671274B2 (de) |
CA (1) | CA2134077C (de) |
DE (1) | DE69330272T2 (de) |
DK (1) | DK0637306T3 (de) |
ES (1) | ES2158861T3 (de) |
GR (1) | GR3036458T3 (de) |
MX (1) | MX9302378A (de) |
NZ (1) | NZ251610A (de) |
PT (1) | PT637306E (de) |
WO (1) | WO1993022309A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0881220A4 (de) * | 1996-02-15 | 1999-04-21 | Mitsubishi Chem Corp | Diarylsultam-derivate |
GB0004549D0 (en) | 2000-02-25 | 2000-04-19 | Isis Innovation | Degradation fragments |
BRPI0416817A (pt) | 2003-11-20 | 2007-03-06 | Janssen Pharmaceutica Nv | 2-quinolinonas e 2-quinoxalinonas 7-fenilalquila substituìdas como inibidores da poli(adp-ribose)polimerase |
EA009875B1 (ru) | 2003-11-20 | 2008-04-28 | Янссен Фармацевтика Н.В. | 6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы |
EA010488B1 (ru) * | 2003-12-05 | 2008-10-30 | Янссен Фармацевтика Н.В. | 6-замещённые 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли (адф-рибоза) полимеразы |
CA2569824C (en) | 2004-06-30 | 2013-03-19 | Janssen Pharmaceutica N.V. | Phthalazine derivatives as parp inhibitors |
WO2006003148A1 (en) * | 2004-06-30 | 2006-01-12 | Janssen Pharmaceutica N.V. | Quinazolinedione derivatives as parp inhibitors |
EP1771422B1 (de) | 2004-06-30 | 2011-02-16 | Janssen Pharmaceutica NV | Chinazolinonderivate als parp-hemmer |
AU2008223793B2 (en) | 2007-03-08 | 2012-08-23 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP and TANK inhibitors |
PL2215075T3 (pl) | 2007-10-26 | 2014-04-30 | Janssen Pharmaceutica Nv | Pochodne chinolinonu jako inhibitory PARP |
EP2260026B1 (de) | 2008-03-27 | 2011-06-22 | Janssen Pharmaceutica, N.V. | Chinazolinonderivate als tubulinpolymerisationshemmer |
EP2271626B1 (de) | 2008-03-27 | 2014-11-26 | Janssen Pharmaceutica, N.V. | Tetrahydrophenanthridinone und tetrahydrocyclopentachinolinone als parp- und tubulinpolymerisierungshemmer |
TWI520949B (zh) * | 2010-07-20 | 2016-02-11 | 錫蘭尼克藥物有限公司 | 使用環醯胺衍生物治療σ受體介導之病症的方法 |
WO2015191554A1 (en) * | 2014-06-09 | 2015-12-17 | Intra-Cellular Therapies, Inc. | Compounds and methods of use to treat schizophrenia |
CN117820199A (zh) * | 2022-09-28 | 2024-04-05 | 瀚远医药有限公司 | 一种酰胺类化合物及其制备Sigma2和5HT2A抑制剂的用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU593194B2 (en) * | 1986-09-26 | 1990-02-01 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives ,and their production and use |
FR2643373B1 (fr) * | 1989-01-10 | 1993-12-31 | Adir Cie | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
WO1991006297A1 (en) * | 1989-10-27 | 1991-05-16 | The Du Pont Merck Pharmaceutical Company | (n-phthalimidoalkyl) piperidines |
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
US5098904A (en) * | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
US5231099A (en) * | 1991-04-15 | 1993-07-27 | Du Pont Merck Pharmaceutical Company | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
DE59209965D1 (de) * | 1991-04-15 | 2002-10-17 | Aventis Pharma Gmbh | Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung |
-
1993
- 1993-03-24 NZ NZ251610A patent/NZ251610A/en unknown
- 1993-03-24 DK DK93908559T patent/DK0637306T3/da active
- 1993-03-24 EP EP93908559A patent/EP0637306B1/de not_active Expired - Lifetime
- 1993-03-24 AT AT93908559T patent/ATE201677T1/de not_active IP Right Cessation
- 1993-03-24 ES ES93908559T patent/ES2158861T3/es not_active Expired - Lifetime
- 1993-03-24 KR KR1019940703742A patent/KR100259107B1/ko not_active IP Right Cessation
- 1993-03-24 CA CA002134077A patent/CA2134077C/en not_active Expired - Fee Related
- 1993-03-24 JP JP51925593A patent/JP3333878B2/ja not_active Expired - Fee Related
- 1993-03-24 WO PCT/US1993/002771 patent/WO1993022309A1/en active IP Right Grant
- 1993-03-24 AU AU39341/93A patent/AU671274B2/en not_active Ceased
- 1993-03-24 DE DE69330272T patent/DE69330272T2/de not_active Expired - Fee Related
- 1993-03-24 PT PT93908559T patent/PT637306E/pt unknown
- 1993-04-23 MX MX9302378A patent/MX9302378A/es unknown
-
2000
- 2000-05-19 US US09/575,023 patent/US20020002174A1/en not_active Abandoned
-
2001
- 2001-08-27 GR GR20010401308T patent/GR3036458T3/el not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,996 patent/US20030083325A1/en not_active Abandoned
-
2003
- 2003-04-09 US US10/410,485 patent/US20030212141A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69330272D1 (de) | 2001-07-05 |
AU3934193A (en) | 1993-11-29 |
KR100259107B1 (ko) | 2000-07-01 |
ES2158861T3 (es) | 2001-09-16 |
ATE201677T1 (de) | 2001-06-15 |
JP3333878B2 (ja) | 2002-10-15 |
KR950701332A (ko) | 1995-03-23 |
US20020002174A1 (en) | 2002-01-03 |
EP0637306B1 (de) | 2001-05-30 |
JPH07506107A (ja) | 1995-07-06 |
GR3036458T3 (en) | 2001-11-30 |
US20030212141A1 (en) | 2003-11-13 |
DE69330272T2 (de) | 2001-10-25 |
EP0637306A1 (de) | 1995-02-08 |
CA2134077A1 (en) | 1993-11-11 |
NZ251610A (en) | 1996-02-27 |
MX9302378A (es) | 1994-05-31 |
WO1993022309A1 (en) | 1993-11-11 |
US20030083325A1 (en) | 2003-05-01 |
PT637306E (pt) | 2001-10-30 |
AU671274B2 (en) | 1996-08-22 |
CA2134077C (en) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE114467T1 (de) | (+)-alpha-(2,3 dimethoxyphenyl)-1-(2- (fluorophenyl)ethyl>-4-piperidinmethanol. | |
DK0637306T3 (da) | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi | |
NO952469D0 (no) | Terapautisk kombinasjon som inneholder interferon | |
ATE215540T1 (de) | Benzofuran-carboxamide und -sulfonamide | |
ES2162110T3 (es) | Derivados de la quinolina antimalaria. | |
IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
DE58902899D1 (de) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. | |
HUP0002836A2 (hu) | Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
NO970573D0 (no) | Ylidenforbindelser og deres fremstilling | |
NO901396L (no) | Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer. | |
NO934311D0 (no) | alfa,omega -diarylalkanderivater, deres fremstilling ag anvendelse ved behandling av dirkulasjonssykdommer og psykoser | |
ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
HUP9802142A2 (hu) | Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására | |
DE69530600D1 (de) | Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung | |
MY102063A (en) | New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins | |
NO993546L (no) | 1,4-dihydropyridinderivater og deres anvendelse i terapi | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
NO975487D0 (no) | 2-azabicyklo£2,2,1|heptanderivater, deres fremstilling og anvendelse | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
UA13003A (uk) | Засіб для стимулюваhhя hавчаhhя та пам'яті |